Fragment Screening for 14 Different Biologically Active RNAs and 10 DNA and protein counter-screens

choleratox

19F-NMR-based fragment screening for 14 completely different biologically lively RNAs and 10 DNA and protein counter-screens

 

We report right here on the nuclear magnetic resonance (NMR) 19 F screening of 14 RNA targets with completely different secondary and tertiary construction to systematically assess druggability of RNAs. Our RNA targets embody consultant bacterial riboswitches that naturally bind with nanomolar affinity and excessive specificity to mobile metabolites of low molecular weight.
Primarily based on counter-screens in opposition to 5 DNAs and 5 proteins, we are able to present that RNA will be particularly focused. To reveal the standard of the preliminary fragment library that has been designed for simple follow-up chemistry, we additional present the best way to enhance binding affinity from an preliminary fragment hit by chemistry that hyperlinks the recognized fragment to the intercalator acridine. Thus, we obtain low micromolar binding affinity with out dropping binding specificity between two completely different terminator buildings.

Predicting persistence of atopic dermatitis in youngsters utilizing scientific attributes and serum proteins

 

Background: Atopic dermatitis (AD) is the commonest inflammatory pores and skin illness in youngsters, with 30% of all these identified creating power or relapsing illness by adolescence. Such illness persistence can’t but be predicted. The intention of the current research was to foretell the pure course of AD utilizing scientific parameters and serum proteins.
Strategies: Sera of 144 youngsters with AD (age 0-Three years) had been analyzed for IgE and 33 cytokines, chemokines, and development components. Affected person illness course till the age of seven years was assessed retrospectively. Unsupervised k-means clustering was carried out to outline illness endotypes.
Recognized components related to AD persistence on the age of seven years had been validated in youngsters with AD in an unbiased cohort (LISA Munich; n=168). Logistic regression and XGBoosting strategies adopted by cross-validation had been utilized to foretell particular person illness outcomes.
Outcomes: Three distinct endotypes had been present in infancy, characterised by a novel inflammatory signature. Elements related to illness persistence had been illness rating (SCORAD), involvement of the limbs, flexural lesion distribution on the age of three years, allergic comorbidities and illness exacerbation by the set off components stress, pollen publicity, and alter in climate.
Persistence was predicted with a sensitivity of 81.8% and a specificity of 82.4%. Elements with a excessive impression on the prediction of persistence had been SCORAD on the age of three years, set off components, and low VEGF serum ranges.
Conclusions: AD in infancy contains three immunological endotypes. Illness persistence will be predicted utilizing serum cytokines and scientific variables.
choleratox

choleratox

Active AHCY, human recombinant

7527-1000
EUR 6578.4

Active AHCY, human recombinant

7527-50
EUR 574.8

Active Recombinant Human CETP

7606-100
EUR 966

Active Recombinant Human CETP

7606-1000
EUR 5214

Active Recombinant Human CETP

7606-20
EUR 314.4

Active SIRT2, human recombinant

7698-10
EUR 314.4

Active SIRT2, human recombinant

7698-1000
EUR 5272.8

Active SIRT2, human recombinant

7698-50
EUR 548.4

Active SIRT7, human recombinant

7846-10
EUR 261.6

Active SIRT7, human recombinant

7846-50
EUR 705.6

Irisin, Active, human recombinant

7852-10
EUR 444

Irisin, Active, human recombinant

7852-50
EUR 1292.4

GAPDH, Active, human recombinant

P1100-10
EUR 170.4

GAPDH, Active, human recombinant

P1100-50
EUR 470.4

Activin-A Human Recombinant Protein, Active

PROTP08476-2 Regular: 10ug
EUR 380.4
Description: Active form Activin-A Human Recombinant produced in e.coli is a homodimeric, non-glycosylated, polypeptide chain containing 2 x 117 amino acids and having a molecular weight of 26.2kDa.;The Active form Activin-A is purified by standard chromatographic techniques.

Activin-B Human Recombinant Protein, Active

PROTP09529 Regular: 10ug
EUR 380.4
Description: Activin B human Recombinant produced in Nicotiana benthamiana plant is a beta-B single chain (aa 293-406) containing 123 amino acids (molecular formula C615H910N178O177S12). Activin B is fused to a 10-His-tag at the N-terminal having the total molecular mass of 14kDa and purified by standard chromatographic techniques.

Recombinant Human Activin-A Active

7-00004 1ug Ask for price

Recombinant Human Activin-A Active

7-00005 5ug Ask for price

Recombinant Human Activin-A Active

7-00006 100µg Ask for price

Recombinant Human Activin-B Active

7-00010 1ug Ask for price

Recombinant Human Activin-B Active

7-00011 5ug Ask for price

Recombinant Human Activin-B Active

7-00012 100µg Ask for price

MMP-14, Active, Human Recombinant

8009-10
EUR 379.2

MMP-14, Active, Human Recombinant

8009-50
EUR 966

Active Cathepsin D, Human Recombinant

9229-10
EUR 294

Active Cathepsin D, Human Recombinant

9229-100
EUR 1358.4

Active Cathepsin D, Human Recombinant

9229-50
EUR 882

Active Cathepsin S, human recombinant

7526-10
EUR 405.6

Active Cathepsin S, human recombinant

7526-50
EUR 1351.2

Active Cathepsin S, human recombinant

7526-500
EUR 10956

Active Cathepsin B, human recombinant

7580-1000
EUR 11739.6

Active Cathepsin B, human recombinant

7580-5
EUR 352.8

Active Cathepsin B, human recombinant

7580-50
EUR 1358.4

Cathepsin K, Active, human recombinant

7600-5
EUR 470.4

Cathepsin K, Active, human recombinant

7600-50
EUR 2734.8

MMP-9, Active, human recombinant

7867-1000
EUR 601.2

MMP-9, Active, human recombinant

7867-500
EUR 398.4

5-Lipoxygenase, Active, Human Recombinant

P1373-200
EUR 379.2

MMP-9, Active, Human Recombinant

P1567-10 10 µg
EUR 417.6

MMP-9, Active, Human Recombinant

P1567-50 50 µg
EUR 612

GCN5 highly active Recombinant Protein

90-345 2 ug
EUR 500.1
Description: GCN5 functions as a histone acetyltransferase (HAT) to promote transcriptional activation. Acetylation of histones gives a specific tag for epigenetic transcription activation. It has significant histone acetyltransferase activity with core histones, but not with nucleosome core particles. In case of HIV-1 infection, it is recruited by the viral protein Tat. It regulates Tat's transactivating activity and may help inducing chromatin remodeling of proviral genes. GCN5 is a component of the Ada Two-A containing (ATAC) complex, a complex with histone acetyltransferase activity on histones H3 and H4.

TIP60 highly active Recombinant Protein

90-347 2 ug
EUR 500.1
Description: TIP60 is the catalytic subunit of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of selected genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome-DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex is required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis and DNA repair. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage. TIP60 directly acetylates and activates ataxia-telangiectasia mutated (ATM). In case of HIV-1 infection, interaction with the viral Tat protein leads to KAT5 polyubiquitination and targets it to degradation.

PARG highly active Recombinant Protein

90-350 2 ug
EUR 500.1
Description: Poly(ADP-ribose) synthesized after DNA damage is only present transiently and is rapidly degraded by poly(ADP-ribose) glycohydrolase. PARG hydrolyzes poly(ADP-ribose) at glycosidic (1''-2') linkage of ribose-ribose bond to produce free ADP-ribose.

NMNAT1 highly active Recombinant Protein

90-354 10 ug
EUR 437.1
Description: Nuclear NMNAT isoform. Catalyzes the formation of NAD+ from nicotinamide mononucleotide (NMN) and ATP. It can also use the deamidated form of nicotinic acid mononucleotide (NAMN) as substrate with the same efficiency. Interacts with PARP-1/ARTD1. Protects against axonal degeneration following mechanical or toxic insults. Widely expressed.

NMNAT1 highly active Recombinant Protein

90-355 50 ug
EUR 619.8
Description: Nuclear NMNAT isoform. Catalyzes the formation of NAD+ from nicotinamide mononucleotide (NMN) and ATP. It can also use the deamidated form of nicotinic acid mononucleotide (NAMN) as substrate with the same efficiency. Interacts with PARP-1/ARTD1. Protects against axonal degeneration following mechanical or toxic insults. Widely expressed.

NMNAT3 highly active Recombinant Protein

90-356 10 ug
EUR 468.6
Description: Mitochondrial NMNAT isoform. Catalyzes the formation of NAD+ from nicotinamide mononucleotide (NMN) and ATP. Can also use the deamidated form of nicotinic acid mononucleotide (NAMN) as substrate with the same efficiency. Can use tiazofurin monophosphate as substrate. Can also use GTP and ITP as nucleotide donors. Also catalyzes the reverse reaction, i. e. the pyrophosphorolytic cleavage of NAD+. For the pyrophosphorolytic activity, mitochondrial NMNAT isoform can use NAD(+), NADH, NAAD, nicotinic acid adenine dinucleotide phosphate (NHD), nicotinamide guanine dinucleotide (NGD) as substrates. Fails to cleave phosphorylated dinucleotides NADP+, NADPH and NAADP+. Protects against axonal degeneration following injury.

NMNAT3 highly active Recombinant Protein

90-357 50 ug
EUR 852.9
Description: Mitochondrial NMNAT isoform. Catalyzes the formation of NAD+ from nicotinamide mononucleotide (NMN) and ATP. Can also use the deamidated form of nicotinic acid mononucleotide (NAMN) as substrate with the same efficiency. Can use tiazofurin monophosphate as substrate. Can also use GTP and ITP as nucleotide donors. Also catalyzes the reverse reaction, i. e. the pyrophosphorolytic cleavage of NAD+. For the pyrophosphorolytic activity, mitochondrial NMNAT isoform can use NAD(+), NADH, NAAD, nicotinic acid adenine dinucleotide phosphate (NHD), nicotinamide guanine dinucleotide (NGD) as substrates. Fails to cleave phosphorylated dinucleotides NADP+, NADPH and NAADP+. Protects against axonal degeneration following injury.

Recombinant MeV Active Nucleocapsid Protein

VAng-Lsx0400-inquire inquire Ask for price
Description: Measles Active Nucleocapsid, recombinant protein from E. coli.

Human SOD Protein (Active)

20-abx060221
  • EUR 376.80
  • EUR 878.40
  • EUR 1554.00
  • 100 ug
  • 1 mg
  • 2 mg

Active Human HSP70 Protein

SPR-103A 0.05 mg
EUR 360
Description: His tagged recombinant human HSP70 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active).

Active Human HSP70 Protein

SPR-103B 0.1 mg
EUR 465.6
Description: His tagged recombinant human HSP70 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active).

Active Human HSP70 Protein

SPR-103C 2x0.1 mg
EUR 802.8
Description: His tagged recombinant human HSP70 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active).

Active Human HSP60 Protein

SPR-104A 0.05 mg
EUR 277.2
Description: His tagged recombinant human HSP60 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active).

Active Human HSP60 Protein

SPR-104B 0.1 mg
EUR 464.4
Description: His tagged recombinant human HSP60 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active).

Active Human HSP60 Protein

SPR-104C 2x0.1 mg
EUR 681.6
Description: His tagged recombinant human HSP60 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active).

Active Human HSC70 Protein

SPR-106A 0.05 mg
EUR 283.2
Description: His tagged recombinant human HSC70 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active).

Active Human HSC70 Protein

SPR-106B 0.1 mg
EUR 372
Description: His tagged recombinant human HSC70 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active).

Active Human HSC70 Protein

SPR-106C 2x0.1 mg
EUR 645.6
Description: His tagged recombinant human HSC70 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active).

Active Human HSP70 Protein

SPR-108A 0.05 mg
EUR 360
Description: Untagged recombinant human HSP70 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active).

Active Human HSP70 Protein

SPR-108B 0.1 mg
EUR 465.6
Description: Untagged recombinant human HSP70 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active).

Active Human HSP70 Protein

SPR-108C 2x0.1 mg
EUR 802.8
Description: Untagged recombinant human HSP70 Protein expressed in E. coli for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active).

Active Human HSP70 Protein

SPR-115A 0.05 mg
EUR 415.2
Description: His tagged recombinant human HSP70 Protein expressed in Baculovirus/Hi5 cells for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active).

Active Human HSP70 Protein

SPR-115B 0.1 mg
EUR 572.4
Description: His tagged recombinant human HSP70 Protein expressed in Baculovirus/Hi5 cells for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active).

Active Human HSP70 Protein

SPR-115C 2x0.1 mg
EUR 975.6
Description: His tagged recombinant human HSP70 Protein expressed in Baculovirus/Hi5 cells for WB, SDS-PAGE, ATPase Activity Assay, Functional Assay, ELISA. This protein is biologically active (ATPase active).

Purified Recombinant Human BMP3 protein, Biologically active

BMP35-R-10 10 ug
EUR 489.6

Purified Recombinant Human BMP4 protein, Biologically active,

BMP45-R-10 10 ug
EUR 1074

Purified Recombinant Human BMP4 protein, Biologically active

BMP45-R-5 5 ug
EUR 634.8

Purified Recombinant Human BMP6 protein, Biologically active

BMP65-R-20 20 ug
EUR 1074

Recombinant purified, human NFkB-p65 protein, active

NFKB651-R-5 5 ug
EUR 781.2

Activin-A Human Recombinant Protein, Plant-Active

PROTP08476-3 Regular: 5ug
EUR 380.4
Description: Active form Activin-A Human Recombinant produced in Plant is a homodimeric, glycosylated, polypeptide chain containing 2 x 116 amino acids and having a molecular weight of 27.4kDa.;The Active form Activin-A is fused to a 6-His tag at N-terminus and purified by standard chromatographic techniques.

Purified, recombinant Human TACE control protein (active)

TACE15-R-10 10 ug
EUR 854.4

Human Recombinant VEGF121 Protein (Sf9), biologically active

VEGF24-R-10 10 ug
EUR 534

Human Recombinant VEGF121 Protein (Sf9), biologically active

VEGF24-R-100 100 ug
EUR 2910

Human Recombinant VEGF121 Protein (E.Coli), biologically active

VEGF25-R-10 10 ug
EUR 534

Human Recombinant VEGF121 Protein (E.Coli), biologically active

VEGF25-R-100 100 ug
EUR 2910

Human Recombinant VEGF165 Protein (E.Coli), biologically active

VEGF26-R-10 10 ug
EUR 534

Human Recombinant VEGF165 Protein (E.Coli), biologically active

VEGF26-R-100 100 ug
EUR 2690.4

Human Recombinant VEGF165 Protein (E.Coli), biologically active

VEGF26-R-1000 1000 ug
EUR 11022

Human Recombinant VEGF165 Protein (Sf9), biologically active

VEGF27-R-10 10 ug
EUR 534

Human Recombinant VEGF165 Protein (HEK), biologically active

VEGF27-R-100 100 ug
EUR 2910

Human Recombinant VEGF165 Protein (Sf9), biologically active

VEGF27-R-1000 1000 ug
EUR 11022

Active Human Caspases Group I, Active Human

K241-3-25
EUR 444

Evaluating completely different sperm separation strategies for ART, via quantitative analysis of p53 protein

Context: Within the final 10 years, assisted reproductive applied sciences (ARTs) have supplied infertile {couples} a possibility to finish their reproductive undertaking. Nevertheless, the excessive failure price could possibly be defined with the complicated human replica system. In ART, the lower of the success is as a result of situations removed from the pure ones.
Goals: The intention of this research is to guage deoxyribonucleic acid (DNA) injury of spermatozoa earlier than and after choice procedures, utilizing a brand new approach capable of quantize sperm DNA injury.
Settings and design: They had been concerned 43 males domiciled completely in two areas with completely different Environmental Impression, HEI (excessive environmental impression) and LEI (Low environmental impression), they’re aged between 24 and 31 years with varied levels of dyspermia.
Topics and strategies: The 43 males had been divided into two teams: 21 in Group A (EIL) and 22 in Group B (EIH). The samples should be aliquoted into components of 0.5 mL: Group (a) Management, no processing; Group (b) Swim-up (SUP) from semen; Group (c) basic SUP; Group (d) density gradient centrifugation (DGC). All samples had been subjected to a quantitative dosage of p53 protein, earlier than and after processing.
Statistical evaluation used: For the event of the chance and significance of the information, the Scholar’s t-test was used.
Outcomes: From our information, it emerges that Teams D and B present a superior high quality about motility, vitality, and apoptosis indexes in comparison with different typical strategies. In Group B, apoptosis is akin to Group D, however they’ve barely decrease about motility and vitality.
Group C is the one which has decrease parameters than the opposite strategies. Concerning the analysis of p53 protein, the outcomes are conflicting with the analysis of apoptosis; in truth, in Group D, the values are considerably larger than the opposite strategies.
Conclusions: Sperm separation is a vital second in ART strategies. From our information, it emerges a better fragility of DNA within the male spermatozoa who reside completely in areas with excessive environmental impression.

Visitor Over Spectacle Clear

SAF1410 EACH
EUR 4.56

Mouse Sushi repeat-containing protein SRPX2 (Srpx2)

1-CSB-EP819154MO
  • EUR 606.00
  • EUR 318.00
  • EUR 2192.40
  • EUR 919.20
  • EUR 1461.60
  • EUR 402.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Mouse Sushi repeat-containing protein SRPX2(Srpx2) expressed in E.coli

Mouse Sushi repeat-containing protein SRPX2 (Srpx2)

1-CSB-BP819154MO
  • EUR 1008.00
  • EUR 398.40
  • EUR 2604.00
  • EUR 1362.00
  • EUR 1894.80
  • EUR 564.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Mouse Sushi repeat-containing protein SRPX2(Srpx2) expressed in Baculovirus

EP Reagent Biuret Reagent

1011601 1L
EUR 42.18

EP Reagent Iodoplatinate Reagent

1046300 200ML
EUR 360.24

EP Reagent Methoxyphenylacetic Reagent

1053601 100ML
EUR 354.54

EP Reagent Molybdovanadic Reagent

1056700 100ML
EUR 42.18

EP Reagent Phosphomolybdotungstic Reagent

1065000 100ML
EUR 161.88

Automatic CO2 Change Over Unit

INC6176 EACH
EUR 1288.2

Forceps Dissecting Turn Over End

D02129 EACH
EUR 4.67

Gas Change Over Unit 30Psi

GAS1000 EACH
EUR 904.02

Gas Change Over Unit 60Psi

GAS1002 EACH
EUR 905.16

Gas Change Over Unit 100Psi

GAS1004 EACH
EUR 922.26

Bolle TG10 Safety Over Glasses

SAF1106 EACH
EUR 8.39

SRPX2 Polyclonal Antibody

28966-100ul 100ul
EUR 302.4

SRPX2 Polyclonal Antibody

28966-50ul 50ul
EUR 224.4

SRPX2 Rabbit pAb

A15434-100ul 100 ul
EUR 369.6

SRPX2 Rabbit pAb

A15434-200ul 200 ul
EUR 550.8

SRPX2 Rabbit pAb

A15434-20ul 20 ul
EUR 219.6

SRPX2 Rabbit pAb

A15434-50ul 50 ul
EUR 267.6

Polyclonal SRPX2 Antibody

APR13540G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SRPX2 . This antibody is tested and proven to work in the following applications:

SRPX2 Blocking Peptide

DF12480-BP 1mg
EUR 234

SRPX2 cloning plasmid

CSB-CL022690HU-10ug 10ug
EUR 602.4
Description: A cloning plasmid for the SRPX2 gene.

Anti-SRPX2 antibody

PAab08240 100 ug
EUR 463.2

anti- SRPX2 antibody

FNab08240 100µg
EUR 658.5
Description: Antibody raised against SRPX2

Anti-SRPX2 antibody

STJ117629 100 µl
EUR 332.4
Description: This gene encodes a secreted protein that contains three sushi repeat motifs. The encoded protein may play a role in the development of speech and language centers in the brain. This protein may also be involved in angiogenesis. Mutations in this gene are the cause of bilateral perisylvian polymicrogyria, rolandic epilepsy, speech dyspraxia and mental retardation.

Anti-SRPX2 Antibody

STJ503134 100 µg
EUR 571.2

Mouse Sushi repeat- containing protein SRPX2, Srpx2 ELISA KIT

ELI-53443m 96 Tests
EUR 1038

Human Sushi repeat- containing protein SRPX2, SRPX2 ELISA KIT

ELI-29242h 96 Tests
EUR 988.8

Bovine Sushi repeat- containing protein SRPX2, SRPX2 ELISA KIT

ELI-18130b 96 Tests
EUR 1113.6

EP Reagent Sulfomolybdic Reagent R3

1086500 1L
EUR 287.28

DURAN Over-Cap 45mm Black Phenolic

BOT2596 PK10
EUR 25.08

Polyclonal SRPX2 Antibody (Internal)

APR13542G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SRPX2 (Internal). This antibody is tested and proven to work in the following applications:

Human SRPX2 shRNA Plasmid

20-abx959053
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Mouse SRPX2 shRNA Plasmid

20-abx976738
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

SRPX2 Polyclonal Conjugated Antibody

C28966 100ul
EUR 476.4

Rat SRPX2 shRNA Plasmid

20-abx989971
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Porcine SRPX2 ELISA Kit

EPS0181 96Tests
EUR 625.2

Rabbit SRPX2 ELISA Kit

ERTS0181 96Tests
EUR 625.2

Rat SRPX2 ELISA Kit

ERS0181 96Tests
EUR 625.2

Goat SRPX2 ELISA Kit

EGTS0181 96Tests
EUR 625.2

Monkey SRPX2 ELISA Kit

EMKS0181 96Tests
EUR 625.2

Mouse SRPX2 ELISA Kit

EMS0181 96Tests
EUR 625.2

Human SRPX2 ELISA Kit

EHS0181 96Tests
EUR 625.2

Bovine SRPX2 ELISA Kit

EBS0181 96Tests
EUR 625.2

Chicken SRPX2 ELISA Kit

ECKS0181 96Tests
EUR 625.2

SRPX2 ELISA KIT|Human

EF003243 96 Tests
EUR 826.8

Canine SRPX2 ELISA Kit

ECS0181 96Tests
EUR 625.2

Sheep SRPX2 ELISA Kit

ESS0181 96Tests
EUR 625.2

Anti-SRPX2 Antibody (Biotin)

STJ503135 100 µg
EUR 703.2

Anti-SRPX2 Antibody (FITC)

STJ503136 100 µg
EUR 703.2

SRPX2 Recombinant Protein (Human)

RP030124 100 ug Ask for price

SRPX2 Recombinant Protein (Rat)

RP231089 100 ug Ask for price

SRPX2 Recombinant Protein (Mouse)

RP175466 100 ug Ask for price

SRPX2 Recombinant Protein (Mouse)

RP175469 100 ug Ask for price

BOP reagent

5-02141 25g Ask for price

BOP reagent

5-02142 100g Ask for price

Chymase reagent

30C-CP1129 5 units
EUR 2622
Description: Purified native Human Chymase reagent

Traut's Reagent

2330-1000
EUR 418.8

Traut's Reagent

2330-500
EUR 248.4

MTS Reagent

2808-1000
EUR 1188

MTS Reagent

2808-250
EUR 438

MTT Reagent

2809-1G
EUR 216

MTT Reagent

2809-5G
EUR 652.8

BOP reagent

A7015-100000 100 g
EUR 240
Description: A peptide coupling reagent. Can be used in the preparation of phenyl esters of amino acids which have been shown to be valuable as blocked derivatives of amino acids in the field of peptide synthesis.

BOP reagent

A7015-25000 25 g
EUR 135.6
Description: A peptide coupling reagent. Can be used in the preparation of phenyl esters of amino acids which have been shown to be valuable as blocked derivatives of amino acids in the field of peptide synthesis.

Bradford reagent

BDE641 100ml
EUR 73.21

Bluing Reagent

BRT030 30 ml
EUR 72

Bluing Reagent

BRT125 125 ml
EUR 75.6

Bluing Reagent

BRT3800 1 Gal.
EUR 220.8

Bluing Reagent

BRT500 500 ml
EUR 91.2

Bluing Reagent

BRT999 1000 ml
EUR 105.6

Leave a Reply

Your email address will not be published.